Verona Pharma (NASDAQ:VRNA) Reaches New 1-Year High

Verona Pharma (NASDAQ:VRNA) Reaches New 1-Year High

2 weeks from now

Dec 30, 2024  · Verona Pharma (NASDAQ:VRNA - Get Free Report) last released its earnings results on Monday, November 4th.The company reported ($0.56) earnings per share (EPS) for …

marketbeat.com

Verona Pharma Stock Soars To All-time High Of $49.05

2 weeks from now

邏 Just 1 week into 2025: These 7 AI-picked stocks are up 9%+ each Unlock Stocks Get 100% ad-free experience Verona Pharma stock soars to all-time high of $49.05

investing.com

Verona Pharma (NASDAQ:VRNA) Sets New 1-Year High - Here's …

2 weeks from now

Dec 23, 2024  · Verona Pharma plc (NASDAQ:VRNA - Get Free Report)'s share price hit a new 52-week high on Monday . The company traded as high as $44.44 and last traded at $43.47, …

marketbeat.com

Verona Pharma Hits New Stock High Amid Strong Performance

2 weeks from now

Jan 7, 2025  · Verona Pharma PLC (NASDAQ: VRNA) has recently reached a remarkable milestone, with its stock price soaring to an all-time high of $49.05. ... In the past year, the …

investorshangout.com

Verona Pharma (NASDAQ:VRNA) Price Target Raised To $74.00

2 weeks from now

5 days ago  · Verona Pharma has a 1-year low of $11.39 and a 1-year high of $51.80. The company has a debt-to-equity ratio of 0.93, a current ratio of 13.03 and a quick ratio of 12.88.

etfdailynews.com

Summary - VRNA - NASDAQ - Weiss Ratings

2 weeks from now

Dec 31, 2024  · Verona Pharma (NASDAQ:VRNA) Hits New 52-Week High and#8211; What's Next? 12/25/2024 - Ticker Report. Verona Pharma (VRNA, $45.28) RSI Indicator left the …

weissratings.com

Verona Pharma Stock Soars To All-time High Of $47 Amid Robust Gains

2 weeks from now

Dec 30, 2024  · In a remarkable display of market performance, Verona Pharma (NASDAQ: VRNA)'s stock has reached an all-time high, touching a price level of $47, just cents shy of its …

investing.com

Verona Pharma Plc (NASDAQ: VRNA) - The Motley Fool

2 weeks from now

Verona Pharma Plc (NASDAQ: VRNA) $46.72 (3.7%) $1.68. Price as of December 26, 2024, 4:00 p.m. ET. Verona Pharma Plc Return vs. S&P. 1 Year ... The small drugmaker reported good …

fool.com

Verona Delivers 250% Return In Less Than A Year - Nasdaq

2 weeks from now

May 17, 2024  · This study is being conducted by Verona's partner in Greater China, Nuance Pharma. Results from the trial are expected in 2025. When we alerted readers to VRNA on …

nasdaq.com

Stifel Financial Corp Invests $474,000 In Verona Pharma Plc …

2 weeks from now

Dec 28, 2024  · Verona Pharma plc has a one year low of $11.39 and a one year high of $46.97. Verona Pharma (NASDAQ:VRNA – Get Free Report) last issued its quarterly earnings results …

etfdailynews.com

Verona Pharma Stock Soars To All-time High Of $30.76

2 weeks from now

Oct 3, 2024  · Verona Pharma PLC (NASDAQ: VRNA) has reached an all-time high, with its stock price soaring to $30.76.This milestone marks a significant achievement for the …

investing.com

Verona Pharma Stock Soars To All-time High Of $47 Amid Robust Gains

2 weeks from now

Dec 30, 2024  · In a remarkable display of market performance, Verona Pharma (NASDAQ: VRNA)'s stock has reached an all-time high, touching a price level of $47, just cents shy of its …

investing.com

Verona Pharma (NASDAQ:VRNA) Sets New 52-Week High

2 weeks from now

Jan 8, 2025  · Verona Pharma plc (NASDAQ:VRNA - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $51.80 and last …

marketbeat.com

Verona Pharma (VRNA) Is On The Move, Here's Why The Trend

2 weeks from now

5 days ago  · Verona Pharma PLC American Depositary Share ... Moreover, VRNA is currently trading at 86.1% of its 52-week High-Low Range, hinting that it can be on the verge of a …

nasdaq.com

Verona Pharma (NASDAQ:VRNA) Upgraded By Roth Capital To …

2 weeks from now

3 days ago  · NASDAQ:VRNA opened at $45.20 on Friday. The stock has a 50-day moving average price of $41.33 and a 200 day moving average price of $31.64. The stock has a …

etfdailynews.com

Verona Pharma Reports Strong Ohtuvayre™ Launch And Provides …

2 weeks from now

Jan 7, 2025  · Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, respectively. More than 3,500 unique prescribers and over …

businessinsider.com

Wall Street Analysts See A 30.65% Upside In Verona Pharma

2 weeks from now

1 day ago  · Verona Pharma PLC American Depositary Share (VRNA) closed the last trading session at $46.69, gaining 9.4% over the past four weeks, but there could be plenty of upside …

nasdaq.com

Wall Street Analysts See A 30.65% Upside In Verona Pharma …

2 weeks from now

1 day ago  · The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Verona Pharma (VRNA). ... the stock to surge 64.9% to reach $77. ... for the current …

zacks.com

Verona Pharma's COPD Drug Ohtuvayre Hits $36M In Q4 Sales, …

2 weeks from now

Jan 7, 2025  · Verona Pharma reports strong performance for their newly launched COPD treatment Ohtuvayre (ensifentrine), with approximately $36 million in net product sales for Q4 …

stocktitan.net

Verona Pharma (NASDAQ:VRNA) Stock Price Up 4.5% - MarketBeat

2 weeks from now

2 days ago  · Shares of Verona Pharma plc (NASDAQ:VRNA - Get Free Report) rose 4.5% on Monday . The stock traded as high as $47.47 and last traded at $47.24. Approximately …

marketbeat.com

Verona Pharma (NASDAQ:VRNA) Earns "Buy" Rating From Truist

2 weeks from now

Jan 8, 2025  · Verona Pharma Stock Down 6.8 %. VRNA traded down $3.35 during trading on Wednesday, hitting $46.20. The company had a trading volume of 1,690,095 shares, …

marketbeat.com